{"id":"jaydess","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT02957292","NCT02349815","NCT02490774","NCT03562624","NCT02706509","NCT03493295","NCT02903888","NCT02574715"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Jaydess","companyId":"bayer","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Bayer","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"}],"genericName":"Jaydess","indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02957292","phase":"Phase 4","title":"A Randomized Controlled Trial to Compare the Menstrual Bleeding Profile Among Copper and 13,5mg Levonorgestrel-releasing IUD Users.","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","isPivotal":false,"enrollment":108,"indication":"Contraception","completionDate":"2020-09-15"},{"nctId":"NCT02349815","phase":"N/A","title":"Pharmacoepidemiological Study (Drug Utilization Study) of JAYDESS Use in Routine Clinical Practice in Sweden","status":"COMPLETED","sponsor":"Bayer","isPivotal":false,"enrollment":10000,"indication":"Contraception","completionDate":"2022-04-01"},{"nctId":"NCT02490774","phase":"Phase 2","title":"Multi-center, Randomized, Comparator-controlled, Single-blind, Parallel-group Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of an Intrauterine System Releasing BAY 1007626, as","status":"TERMINATED","sponsor":"Bayer","isPivotal":false,"enrollment":174,"indication":"Contraception","completionDate":"2016-07-22"},{"nctId":"NCT03562624","phase":"Phase 2","title":"Multi-center, Randomized, Comparator-controlled, Single-blind, Parallel-Group Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of an Intrauterine System (BAY987443) With Three Di","status":"COMPLETED","sponsor":"Bayer","isPivotal":false,"enrollment":177,"indication":"Contraception","completionDate":"2019-08-01"},{"nctId":"NCT02706509","phase":"Phase 4","title":"Comparison Between the Analgesic Affects of Tramadol® and \"Verbal Anesthesia\" on Pain Management Associated With the Insertion of Jaydess® in Nulliparous Women","status":"UNKNOWN","sponsor":"Meir Medical Center","isPivotal":false,"enrollment":100,"indication":"IUD Insertion Complication","completionDate":"2018-12"},{"nctId":"NCT03493295","phase":"N/A","title":"Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern","status":"COMPLETED","sponsor":"Bayer","isPivotal":false,"enrollment":587,"indication":"Contraception","completionDate":"2021-03-15"},{"nctId":"NCT02903888","phase":"N/A","title":"A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years","status":"COMPLETED","sponsor":"Bayer","isPivotal":false,"enrollment":886,"indication":"Intrauterine Devices, Medicated","completionDate":"2017-12-23"},{"nctId":"NCT02574715","phase":"N/A","title":"A Cross-sectional, Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess® as Their Contraceptive Method - The JULIA Study.","status":"COMPLETED","sponsor":"Bayer","isPivotal":false,"enrollment":1039,"indication":"Quality of Life","completionDate":"2016-09-28"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}